People with diabetes lost up to 34 pounds taking Eli Lilly drug, company says

helped obese patients with Type 2 diabetes lose 15% of their body weight, or about 34 pounds, on average, in a late-stage clinical trial, the drugmaker said in a news release Thursday.

— which is sold under the brand name Mounjaro for Type 2 diabetes — can be used as an effective weight loss aid. found that tirzepatide helped patients without Type 2 diabetes lose 22.5% of their body weight on average, or about 52 pounds. Patients in that trial had obesity or were overweight.

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

People with diabetes lost up to 34 pounds taking Eli Lilly drug, company saysAn Eli Lilly drug helped obese patients with Type 2 diabetes lose 15% of their body weight, or about 34 pounds, on average, in a late-stage clinical trial, the drugmaker says.
Source: NBCNews - 🏆 10. / 86 Read more »

Eli Lilly stock up premarket as company’s Q1 revenue beats and it raises guidanceEli Lilly & Co. shares rose 2% premarket Thursday, after the company posted first-quarter earnings showing a revenue beat and raised its full-year guidance....
Source: MarketWatch - 🏆 3. / 97 Read more »